Molecular Neuroscience Overview

Principles

Definition

Molecular neuroscience is a subdiscipline of neuroscience that investigates the nervous system at the molecular level, focusing on the structure, function, and interactions of molecules within neurons and glial cells to understand fundamental neural processes, development, and disease mechanisms.

Ontological type

Disease Mechanisms

Core Mechanisms

Experimental Techniques

Key developments

Key Figures

Neurochemical Mapping era

Urban Ungerstedt [1], active at Karolinska Institutet [3] and the University of Gothenburg [4] during this era, helped shape anatomical neurochemical mapping. His key contribution, exemplified by Stereotaxic Mapping of the Monoamine Pathways in the Rat Brain [7] (1971), established spatially resolved monoamine maps that linked regional chemistry to function and provided the empirical substrate for hypothesis-driven pharmacology and circuit-level interpretations. Paul Greengard [2], affiliated with the University of Pennsylvania [5] and the Albert Einstein College of Medicine [6] during this period, helped connect monoaminergic signaling to intracellular second-messenger pathways. His work on dopamine-sensitive adenylate cyclase, including the 1972 paper Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor” [8], and the 1974 paper Dopamine-Sensitive Adenylate Cyclase in Mammalian Brain: A Possible Site of Action of Antipsychotic Drugs [9], identified a dopamine-regulated intracellular mechanism as a pivotal site for signaling and antipsychotic drug action in the brain.

Dopamine Receptor Molecularization era

Pierre Sokoloff [1] connected with Karolinska Institutet [3] and Université Paris Cité [4] during the Dopamine Receptor Molecularization era. He contributed to molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics [7], to the localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA [8], and to the demonstration of widespread distribution of brain dopamine receptors evidenced with [ <sup>125</sup> I]Iodosulpride, a Highly Selective Ligand [9]. Gary Lynch [2] connected with Harvard University [5] and the University of Pennsylvania [6] during this era. His sole listed paper, 'Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5' [10], illustrated how NMDA receptor pharmacology and synaptic plasticity intersected with dopamine signaling research, underscoring the era's focus on molecular mechanisms of learning and memory.

Synaptic Proteopathy era

Ted M. Dawson [1] is a prominent neuroscience researcher associated with Harvard University [3] and the Forest Institute [4] during the Synaptic Proteopathy era. A central contribution from this era is his work, notably the 2017 paper Neurotoxic reactive astrocytes are induced by activated microglia [6], which demonstrated that activated microglia induce neurotoxic reactive astrocytes, highlighting glial crosstalk as a critical driver of synaptic vulnerability and proteostasis disruption. Valina L. Dawson [2] is linked to the Forest Institute [4] and Johns Hopkins University [5] during this era. Her key contribution cited here is the same 2017 paper Neurotoxic reactive astrocytes are induced by activated microglia [6], underscoring how glial reactivity shapes proteostasis and synaptic resilience, providing a framework for how proteopathic processes may propagate through neurodegenerative circuits.